Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia
Yingjun Wang(South China University of Technology), Ken H. Young(Duke Medical Center), Fredrick B. Hagemeister(The University of Texas MD Anderson Cancer Center), Sheeba K. Thomas(The University of Texas MD Anderson Cancer Center), Feng Zhu(Xuzhou Medical College), Zijun Y. Xu‐Monette(Duke University), Vasantha Lakshmi Gali(The University of Texas MD Anderson Cancer Center), Robert Z. Orlowski(University of North Carolina at Chapel Hill), Manman Deng(Xiamen University), Xiaosheng Fang(Shandong Provincial Hospital), Mingzhi Zhang(Chinese Academy of Sciences), Yong Li(Baylor College of Medicine), Hans Chulhee Lee(The University of Texas MD Anderson Cancer Center), Donna M. Weber(The University of Texas MD Anderson Cancer Center), Dahlia Sano(The University of Texas MD Anderson Cancer Center)
Cited by 29
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718